je.st
news
Home
› Nerviano Medical Sciences And Servier Announce A Collaboration And License Agreement For A Novel Anticancer Drug
Nerviano Medical Sciences And Servier Announce A Collaboration And License Agreement For A Novel Anticancer Drug
2013-07-30 09:00:00| drugdiscoveryonline News Articles
Nerviano Medical Sciences, the largest pharmaceutical R&D facility in Italy, one of the leading oncology-focused, integrated discovery and development companies in Europe, and Servier, a leading research-based European pharmaceutical company recently announced a collaboration and worldwide license agreement to further develop and commercialize first-in-class Nerviano compounds inhibiting the protein kinase TTK/MPS1
Tags: agreement
medical
license
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||